HK1206031A1 - 抗菌化合物 - Google Patents

抗菌化合物

Info

Publication number
HK1206031A1
HK1206031A1 HK15106715.4A HK15106715A HK1206031A1 HK 1206031 A1 HK1206031 A1 HK 1206031A1 HK 15106715 A HK15106715 A HK 15106715A HK 1206031 A1 HK1206031 A1 HK 1206031A1
Authority
HK
Hong Kong
Prior art keywords
antibacterial compounds
antibacterial
compounds
Prior art date
Application number
HK15106715.4A
Other languages
English (en)
Inventor
.魯尼斯
‧帕爾默
‧皮特
‧阿克斯福德
‧戴維斯
Original Assignee
Biota Europe Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Europe Ltd filed Critical Biota Europe Ltd
Publication of HK1206031A1 publication Critical patent/HK1206031A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK15106715.4A 2012-03-22 2015-07-14 抗菌化合物 HK1206031A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261614044P 2012-03-22 2012-03-22
PCT/AU2013/000286 WO2013138860A1 (en) 2012-03-22 2013-03-21 Antibacterial compounds

Publications (1)

Publication Number Publication Date
HK1206031A1 true HK1206031A1 (zh) 2015-12-31

Family

ID=49212365

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106715.4A HK1206031A1 (zh) 2012-03-22 2015-07-14 抗菌化合物

Country Status (6)

Country Link
US (3) US9604976B2 (zh)
EP (1) EP2828257B1 (zh)
JP (1) JP2015514063A (zh)
CN (1) CN104302645A (zh)
HK (1) HK1206031A1 (zh)
WO (1) WO2013138860A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012097274A1 (en) 2011-01-14 2012-07-19 Vertex Pharmaceuticals Incorporation Process of making gyrase and topoisomerase iv inhibitors
RU2625305C2 (ru) 2011-01-14 2017-07-13 Сперо Тринем, Инк. Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины
AU2012205415B2 (en) 2011-01-14 2017-02-02 Spero Therapeutics, Inc. Pyrimidine gyrase and topoisomerase IV inhibitors
TWI554515B (zh) 2011-06-20 2016-10-21 維泰克斯製藥公司 旋轉酶(gyrase)及拓樸異構酶抑制劑之磷酸酯
US9604976B2 (en) * 2012-03-22 2017-03-28 Spero Gyrase, Inc. Antibacterial compounds
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
US9018216B2 (en) 2012-07-18 2015-04-28 Vertex Pharmaceuticals Incorporated Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
CA2938459A1 (en) * 2014-02-03 2015-08-06 Spero Gyrase, Inc. Antibacterial compounds
AU2015342017B2 (en) 2014-11-03 2020-02-06 Bayer Pharma Aktiengesellschaft Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
US9988367B2 (en) 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
EP3452457B1 (en) 2016-05-03 2020-03-18 Bayer Pharma Aktiengesellschaft Oxoalkyl-substituted phenyltriazole derivatives and uses thereof
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents
CN115124544B (zh) * 2022-07-20 2023-06-23 四川抗菌素工业研究所金华分所 一种螺[四氢呋喃-3,3’-吲哚啉]骨架物及其晶型和其制备方法与用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101048381A (zh) * 2004-09-09 2007-10-03 中外制药株式会社 新型四氢咪唑衍生物及其用途
GB0724349D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Antibacterial agents
GB0612428D0 (en) * 2006-06-22 2006-08-02 Prolysis Ltd Antibacterial agents
GB0724342D0 (en) 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009147431A1 (en) * 2008-06-04 2009-12-10 Astrazeneca Ab Thiazolo [5, 4-b] pyridine and oxazolo [5, 4-b] pyridine derivatives as antibacterial agents
WO2009156966A1 (en) 2008-06-25 2009-12-30 Ranbaxy Laboratories Limited Benzothiazoles and aza-analogues thereof use as antibacterial agents
WO2010056320A2 (en) * 2008-11-11 2010-05-20 Tyrogenex, Inc. Pi3k/mtor kinase inhibitors
AU2011313820A1 (en) 2010-10-08 2013-04-11 Biota Europe Ltd Antibacterial compounds
EP2794569B1 (en) * 2011-12-21 2017-05-10 Biota Europe Ltd Heterocyclic urea compounds
US9604976B2 (en) * 2012-03-22 2017-03-28 Spero Gyrase, Inc. Antibacterial compounds

Also Published As

Publication number Publication date
JP2015514063A (ja) 2015-05-18
EP2828257A4 (en) 2015-08-26
US20130252938A1 (en) 2013-09-26
US20150329530A1 (en) 2015-11-19
CN104302645A (zh) 2015-01-21
US8906902B2 (en) 2014-12-09
WO2013138860A1 (en) 2013-09-26
US9604976B2 (en) 2017-03-28
US20170260178A1 (en) 2017-09-14
EP2828257A1 (en) 2015-01-28
EP2828257B1 (en) 2017-07-26

Similar Documents

Publication Publication Date Title
HRP20181889T1 (hr) Spojevi tetrahidropirazolopirimidina
HK1245780B (zh) 咪唑並吡咯烷酮化合物
EP2925129A4 (en) PRO-NEUROGENIC COMPOUNDS
GB201209138D0 (en) Compounds
GB201214750D0 (en) Compounds
GB201215357D0 (en) Compounds
EP2887803A4 (en) PRO-NEUROGENIC COMPOUNDS
HK1206726A1 (zh) 咪唑並三嗪酮化合物
HK1206031A1 (zh) 抗菌化合物
GB201204985D0 (en) Compounds
GB201204125D0 (en) Compounds
EP2763539A4 (en) ANTIBACTERIAL COMPOUNDS
HK1211283A1 (zh) 化合物
GB201209096D0 (en) Compounds
HK1212677A1 (zh) 新型抗細菌化合物
HK1206356A1 (zh) -取代的氰基吡唑化合物
GB201219820D0 (en) Compounds
GB201217310D0 (en) Compounds
HK1210954A1 (zh) 抗細菌化合物
GB201211202D0 (en) Antimicrobial compounds
IL239207A0 (en) Antibacterial compounds
GB201211203D0 (en) Antimicrobial compounds
GB201223429D0 (en) Compounds
GB201220029D0 (en) Compounds
GB201219819D0 (en) Compounds